miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2

Objective Downregulation of miR-17-5p has been reported in several cancers, but whether and how miR-17-5p is downregulated in hepatocellular carcinoma (HCC) is unknown. Here, we examined whether miR-17-5p is downregulated in HCC and whether that affects expression of its target gene encoding transfo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical & translational oncology 2023-10, Vol.25 (10), p.2960-2971
Hauptverfasser:	Liu, Hao-Tian, Luo, Cheng-Piao, Jiang, Meng-Jie, Deng, Zhu-Jian, Teng, Yu-Xian, Su, Jia-Yong, Pan, Li-Xin, Ma, Liang, Guo, Ping-Ping, Zhong, Jian-Hong
Format:	Artikel
Sprache:	eng
Schlagworte:	Medicine Medicine & Public Health Oncology Research Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!